The effect of amantadine and Q10 in fatigue of the Multiple Sclerosis patients
Not Applicable
- Conditions
- Fatigue in multiple sclerosis patients.Multiple sclerosis
- Registration Number
- IRCT2013092814792N1
- Lead Sponsor
- Kermanshah University Of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Informed consent form and questionnaire filling; FSS greater than or equal to 4.0
Exclusion criteria: Use of sedative-hypnotic drugs in the last 2 months;Pregnancy or lactation; Congestive heart failure;kidney or liver disease; psychiatric disorders; major Depression;asthma;anemia; hyperthyroidism;sleep disorders;diabetes and high blood pressure; alcohol abuse;drug abuse; HMG coa reductase inhibitors; beta blockers; calcium channel blockers; statins, levodopa;Sleep disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fatige. Timepoint: The beginning and 4 weeks after the end of study. Method of measurement: FSS Questionnaire.
- Secondary Outcome Measures
Name Time Method Drug side effects. Timepoint: Bigenning,during the study,and four weeks after the end of study. Method of measurement: Ask the patients.